NEOMYCIN SULFATE | BETAMETHASONE VALERATE - Результати пошуку

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

betnovate n 0.1/0.5 %w/w ointment

glaxo laboratories limited - betamethasone valerate neomycin sulfate - ointment - 0.1/0.5 %w/w

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

betnovate-n 0.1% / 0.5% w/w cream 0.1/0.5 %w/w cream

glaxosmithkline (ireland) limited - betamethasone valerate neomycin sulfate - cream - 0.1/0.5 %w/w

Вірменія - англійська - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

betamed-n ointment ointment

medpharma pharm. & chem. inds llc - betamethasone (betamethasone valerate), neomycin (neomycin sulphate) - ointment - 0,1%+ 0,5%

Австралія - англійська - APVMA (Australian Pesticides and Veterinary Medicines Authority)

neomycin penicillin 100/200 aqueous suspension for intramuscular injection

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

betnovate n

glaxosmithkline nz limited - betamethasone valerate 0.1%; neomycin sulfate 0.35% - topical cream - 0.1%/0.35% - active: betamethasone valerate 0.1% neomycin sulfate 0.35%

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

betnovate n

glaxosmithkline nz limited - betamethasone valerate 0.1%; neomycin sulfate 0.35% - topical ointment - 0.1%/0.35% - active: betamethasone valerate 0.1% neomycin sulfate 0.35%

betamed-n cream cream

medpharma pharm. & chem. inds llc - betamethasone (betamethasone valerate), neomycin (neomycin sulphate) - cream - 0.1%+ 0.5%

США - англійська - NLM (National Library of Medicine)

neomycin and polymyxin b sulfates, bacitracin zinc, and hydrocortisone- neomycin sulfate, polymyxin b sulfate, bacitracin zinc a

mwi - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - neomycin 3.5 mg in 1 g - neomycin and polymyxin b sulfates, bacitracin zinc, and hydrocortisone ophthalmic ointment is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye (see clinical pharmacology: microbiology). the particular anti-infective drugs in this product

США - англійська - NLM (National Library of Medicine)

neomycin and polymyxin b sulfates and bacitracin zinc with hydrocortisone acetate ointment

physicians total care, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj) - neomycin sulfate 3.5 mg in 1 g - neomycin and polymyxin b sulfates and bacitracin zinc with hydrocortisone acetate ophthalmic ointment is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye (see clinical pharmacology: microbiology ). the particular anti-infect

США - англійська - NLM (National Library of Medicine)

neomycin, polymyxin b sulfates and hydrocortisone suspension

physicians total care, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - neomycin sulfate 3.5 mg in 1 ml - neomycin and polymyxin b sulfates and hydrocortisone ophthalmic suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye (see clinical pharmacology: microbiology ). the particular anti-infective drugs in this produ